| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm |
| Cash burn (monthly) | 11.71 mm | 3.59 mm | 8.15 mm | 6.57 mm | 7.81 mm | 5.48 mm |
| Cash used (since last report) | 47.12 mm | 14.43 mm | 32.77 mm | 26.42 mm | 31.43 mm | 22.03 mm |
| Cash remaining | -11.88 mm | 20.81 mm | 2.47 mm | 8.82 mm | 3.80 mm | 13.20 mm |
| Runway (months of cash) | -1.0 | 5.8 | 0.3 | 1.3 | 0.5 | 2.4 |
| 13F holders | Current |
|---|---|
| Total holders | 96 |
| Opened positions | 21 |
| Closed positions | 14 |
| Increased positions | 25 |
| Reduced positions | 27 |
| 13F shares | Current |
|---|---|
| Total value | 538.34 bn |
| Total shares | 24.92 mm |
| Total puts | 9.00 k |
| Total calls | 9.80 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Ra Capital Management | 2.54 mm | $65.28 bn |
| Avoro Capital Advisors | 2.22 mm | $57.13 bn |
| BlackRock | 1.75 mm | $45.08 bn |
| Hydra | 1.70 mm | $0.00 |
| Blue Owl Capital | 1.53 mm | $39.35 bn |
| TCG Crossover Management | 1.48 mm | $37.99 bn |
| PFE Pfizer | 1.27 mm | $46.46 mm |
| Jennison Associates | 1.15 mm | $29.62 bn |
| Vanguard | 1.06 mm | $27.32 bn |
| Qiming U.S. Ventures Management | 741.69 k | $19.07 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jan 25 | Ryan F. Robinson | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Middlekauff W Bradford | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Susan Dana Jones | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Kevin Bruce Johnson | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 21 Aug 24 | Sandeep Chidambar Kulkarni | Common Stock | Buy | Acquire P | Yes | No | 14.85 | 1,779 | 26.42 k | 7,000 |
